![]() | Up a level |
Bachert, C., Moesges, R., Virchow, J. C., Wahn, U., Kuhl, H. C. and Klimek, L. (2015). MP29-02*provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany. Allergy, 70. S. 505 - 506. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Klimek, L., Virchow, J. C., Wahn, U., Moesges, R., Kuhl, H-C and Bachert, C. (2015). MP29-02*provides effective relief in real life in all patients regardless of ARIA-defined severity: results from Germany. Allergy, 70. S. 503 - 504. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Klimek, L., Virchow, J. C., Wahn, U., Moesges, R., Kuhl, H-C and Bachert, C. (2015). MP29-02*provides effective relief in real life in patients previously treated with mono- and multiple-therapy: results from Germany. Allergy, 70. S. 503 - 504. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Klimek, L., Virchow, J. C., Wahn, U., Moesges, R., Munzel, U. and Bachert, C. (2014). Real-world effectiveness of a new allergic rhinitis therapy (MP29-02). Allergy, 69. S. 322 - 323. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Klimek, L., Virchow, J. C., Wahn, U., Kuhl, H-C and Bachert, C. (2015). MP29-02*provides effective AR symptom control in real life in patients previously treated with, or currently receiving immunotherapy: results from Germany. Allergy, 70. S. 501 - 503. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Virchow, J. C., Klimek, L., Wahn, U., Moesges, R., Kuhl, H. C. and Bachert, C. (2015). MP29-02*provides effective AR symptom control in real life in previous or potential treatment failure patients: results from Germany. Allergy, 70. S. 503 - 505. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Virchow, J. C., Moesges, R., Fenton, J., Munzel, U. and Schmid-Grendelmeier, B. (2014). A new allergic rhinitis therapy (MP29-02) provides substantial and complete ocular symptom relief. Allergy, 69. S. 324 - 325. HOBOKEN: WILEY. ISSN 1398-9995
Wahn, U., Bachert, C., Virchow, J. C., Moesges, R., Kuhl, H. C. and Klimek, L. (2015). MP29-02*provides effective AR symptom control in real life regardless of number of previous clinic visits: results from Germany. Allergy, 70. S. 499 - 500. HOBOKEN: WILEY. ISSN 1398-9995